Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy-Reference-Cited by-同舟云学术

Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy

Published:2013-08-26 Issue:8 Volume:8 Page:e72027
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Colella Pasqualina,Sommella Andrea,Marrocco Elena,Di Vicino Umberto,Polishchuk Elena,Garrido Marina Garcia,Seeliger Mathias W.,Polishchuk Roman,Auricchio Alberto

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference63 articles.

1. An update on the genetics of usher syndrome;JM Millan;J Ophthalmol,2011

2. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B;T Hashimoto;Gene Ther,2007

3. A type VII myosin encoded by the mouse deafness gene shaker-1;F Gibson;Nature,1995

4. Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells;T Self;Development,1998

5. Shaker mice and a peek into the House of Usher;D Saw Jr;Exp Anim,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of two major isoforms of MYO7A in the retina: Considerations for gene therapy of Usher syndrome type 1B;Vision Research;2023-11

2. Pathogenesis and Treatment of Usher Syndrome Type IIA;Asia-Pacific Journal of Ophthalmology;2022-07

3. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders;Expert Opinion on Biological Therapy;2022-01-06

4. Current Approaches to the Management of Usher Syndrome for the Clinician;Perspectives of the ASHA Special Interest Groups;2020-08-17

5. A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome;Frontiers in Cellular Neuroscience;2020-07-09